Back
Halozyme Therapeutics Stock Price Chart
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Buy
78
HALO
Halozyme Therapeutics
Last Price:
43.85
Seasonality Move:
1.35%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight selling pressure.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.81 | Buy |
| 20-day SMA: | 39.87 | Buy |
| 50-day SMA: | 40.27 | Buy |
| 200-day SMA: | 38.79 | Buy |
| 8-day EMA: | 42.05 | Buy |
| 20-day EMA: | 40.73 | Buy |
| 50-day EMA: | 39.83 | Buy |
| 200-day EMA: | 39.04 | Buy |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.95 | Buy |
| Relative Strength Index (14 RSI): | 70.72 | Buy |
| Chaikin Money Flow: | -207779 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.02 - 41.46) | Buy |
| Bollinger Bands (100): | (35.52 - 40.9) | Buy |
Halozyme Therapeutics Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
- Halozyme Therapeutics share price is 43.61 while HALO 8-day simple moving average is 41.81, which is a Buy signal.
- The stock price of HALO is 43.61 while Halozyme Therapeutics 20-day SMA is 39.87, which makes it a Buy.
- Halozyme Therapeutics 50-day simple moving average is 40.27 while HALO share price is 43.61, making it a Buy technically.
- HALO stock price is 43.61 and Halozyme Therapeutics 200-day simple moving average is 38.79, creating a Buy signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
78
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a Buy
The current Halozyme Therapeutics [HALO] share price is $43.61. The Score for HALO is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
5.55B
Price in USD:
43.61
Share Volume:
900.38K
Halozyme Therapeutics 52-Week Range
52-Week High:
45.00
52-Week Low:
31.86
Buy
78
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?
The Halozyme Therapeutics stock price is 43.61 USD today. -
Will HALO stock go up or go down?
Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Halozyme Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
- Halozyme Therapeutics share price is 43.61 while HALO 8-day exponential moving average is 42.05, which is a Buy signal.
- The stock price of HALO is 43.61 while Halozyme Therapeutics 20-day EMA is 40.73, which makes it a Buy.
- Halozyme Therapeutics 50-day exponential moving average is 39.83 while HALO share price is 43.61, making it a Buy technically.
- HALO stock price is 43.61 and Halozyme Therapeutics 200-day simple moving average is 39.04, creating a Buy signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.05 per share, an increase this year of $0.85 per share, and an increase next year of $0.83 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
- HALO Moving Average Covergence Divergence (MACD) indicator is 0.95, suggesting Halozyme Therapeutics is a Buy
- Halozyme Therapeutics Relative Strength Index (RSI) is 70.72, which suggest Halozyme Therapeutics is overbought
- The Bollinger Bands (25) for Halozyme Therapeutics is (38.02 - 41.46), which suggest Halozyme Therapeutics is a Buy
- The Bollinger Bands (100) for Halozyme Therapeutics is (35.52 - 40.9), which suggest Halozyme Therapeutics is a Buy
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.